Drug Profile
Research programme: antimicrobial therapeutics - Amicrobe/University of California
Alternative Names: Amicidin-α™; Amicidin-β™Latest Information Update: 28 Apr 2022
Price :
$50
*
At a glance
- Originator Amicrobe; University of California at Los Angeles
- Developer Amicrobe
- Class Anti-infectives; Antibacterials; Antifungals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Infections